Article
Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes.
Microbiology spectrum - 26 Oct 2022
Dietrich Alina, Steffens Ursula, Gajdiss Mike, Boschert Anna-Lena, Dröge Jana Katharina, Szekat Christiane, Sass Peter, Malik Imran T, Bornikoel Jan, Reinke Laura, Maček Boris, Franz-Wachtel Mirita, Nieselt Kay, Harbig Theresa, Scherlach Kirstin, Brötz-Oesterhelt Heike, Hertweck Christian, Sahl Hans-Georg, Bierbaum Gabriele
Abstract excerpt
Resistance to antibiotics is an increasing problem and necessitates novel antibacterial therapies. The polyketide antibiotics cervimycin A to D are natural products of Streptomyces tendae HKI 0179 with promising activity against multidrug-resistant staphylococci and vancomycin-resistant enterococci. To initiate mode of action studies, we selected cervimycin C- and D-resistant (CmR) Staphylococcus aureus strains....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
